P951: CLINICAL AND LABORATORY CHARACTERISTICS, COURSE AND OUTCOME OF COVID19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA

• A. Sretenovic,
• M. Mitrovic,
• T. Adzic Vukicevic,
• Z. Bukumiric,
• O. Markovic,
• M. Zdravkovic,
• D. Antic,
• J. Bila

Affiliations

A. Sretenovic

1 Myeloma department, Clinic of hematology University Clinical centre of Serbia

M. Mitrovic

1 Myeloma department, Clinic of hematology University Clinical centre of Serbia

T. Adzic Vukicevic

2 Pulmology, COVID Hospital “Batajnica”, University Clinical Center of Serbia

Z. Bukumiric

3 Medical Faculty, University of Belgrade

O. Markovic

4 Hematology, Clinical-Hospital Center “Bezanijska Kosa”

M. Zdravkovic

4 Hematology, Clinical-Hospital Center “Bezanijska Kosa”

D. Antic

5 Lymphoma department, Clinic of hematology University Clinical centre of Serbia, Belgrade, Serbia

J. Bila

1 Myeloma department, Clinic of hematology University Clinical centre of Serbia